Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1967 1
1969 1
1970 2
1971 2
1972 2
1974 1
1975 4
1976 3
1977 3
1978 3
1979 2
1980 7
1981 4
1982 4
1983 10
1984 4
1985 11
1986 19
1987 26
1988 26
1989 25
1990 29
1991 30
1992 33
1993 39
1994 33
1995 31
1996 67
1997 85
1998 75
1999 89
2000 123
2001 186
2002 217
2003 243
2004 283
2005 326
2006 321
2007 314
2008 349
2009 378
2010 436
2011 516
2012 515
2013 562
2014 565
2015 642
2016 653
2017 622
2018 666
2019 740
2020 697
2021 676
2022 647
2023 610
2024 265

Text availability

Article attribute

Article type

Publication date

Search Results

11,208 results

Results by year

Filters applied: . Clear all
Page 1
Ru(II)-diimine complexes and cytochrome P450 working hand-in-hand.
Eidenschenk C, Cheruzel L. Eidenschenk C, et al. J Inorg Biochem. 2020 Dec;213:111254. doi: 10.1016/j.jinorgbio.2020.111254. Epub 2020 Sep 12. J Inorg Biochem. 2020. PMID: 32979791 Free PMC article. Review.
Non-covalent and subsequently covalently attached Ru(II) complexes were used to promote rapid intramolecular electron transfer in bacterial P450 enzymes. Photocatalytic activity with Ru(II)-modified P450 enzymes was achieved under reductive conditions …
Non-covalent and subsequently covalently attached Ru(II) complexes were used to promote rapid intramolecular electron transfer …
Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy.
Karges J. Karges J. BME Front. 2023 Aug 1;4:0024. doi: 10.34133/bmef.0024. eCollection 2023. BME Front. 2023. PMID: 37849670 Free PMC article. Review.
Ru(II) polypyridine complexes have attracted much attention as anticancer agents because of their unique photophysical, photochemical, and biological properties. ...Among the different strategies employed to overcome these pharmacological limitations, many research …
Ru(II) polypyridine complexes have attracted much attention as anticancer agents because of their unique photophysical, photoc …
Unlocking the Potential of Ru(II) Dual-action Compounds with the Power of the Heavy-atom Effect.
Toupin NP, Steinke SJ, Herroon MK, Podgorski I, Turro C, Kodanko JJ. Toupin NP, et al. Photochem Photobiol. 2022 Mar;98(2):378-388. doi: 10.1111/php.13573. Epub 2021 Dec 24. Photochem Photobiol. 2022. PMID: 34866185
We report the synthesis, photochemical and biological characterization of two new Ru(II) photoactivated complexes based on [Ru(tpy)(Me(2) bpy)(L)](2+) (tpy = 2,2':6',2''-terpyridine, Me(2) bpy = 6,6'-dimethyl-2,2'-bipyridine), where L = pyridyl-BODIPY (pyBOD) …
We report the synthesis, photochemical and biological characterization of two new Ru(II) photoactivated complexes based on [ …
Facile Light-Induced Transformation of [Ru(II)(bpy)(2)(bpyNO)](2+) to [Ru(II)(bpy)(3)](2).
Karbakhsh Ravari A, Pineda-Galvan Y, Huynh A, Ezhov R, Pushkar Y. Karbakhsh Ravari A, et al. Inorg Chem. 2020 Oct 5;59(19):13880-13887. doi: 10.1021/acs.inorgchem.0c01446. Epub 2020 Sep 14. Inorg Chem. 2020. PMID: 32924462
These pathways were found to have comparable deltaG. A reduction of [Ru(IV)O(bpy)(2)(bpy(out))](2+) may result in water elimination and formation of [Ru(II)(bpy)(3)](2+). ...Thus, [Ru(II)(bpy)(2)(bpyNO)](2+) has potential as a light-induced oxid …
These pathways were found to have comparable deltaG. A reduction of [Ru(IV)O(bpy)(2)(bpy(out))](2+) may result in water elimination a …
Effect of electronic structure of energy transfer in bimetallic Ru(II)/Os(II) complexes.
Dai W, Yu S, Kong C, Zhao D, He C, Liu Z, Dong J, Liu JJ, Cheng F. Dai W, et al. Dalton Trans. 2023 Jan 24;52(4):990-999. doi: 10.1039/d2dt03709b. Dalton Trans. 2023. PMID: 36601979
Novel monometallic (mu-LL')Ru, Ru(mu-LL'), homobimetallic Ru(mu-LL')Ru, and heterodimetallic Ru(mu-LL')Os and Os(mu-LL')Ru complexes based on two asymmetrical ligands LL' (where LL' = L(1)L(1'), L(2)L(2')) have been synthesized and charac …
Novel monometallic (mu-LL')Ru, Ru(mu-LL'), homobimetallic Ru(mu-LL')Ru, and heterodimetallic Ru(mu-LL')Os …
Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.
Li A, Turro C, Kodanko JJ. Li A, et al. Acc Chem Res. 2018 Jun 19;51(6):1415-1421. doi: 10.1021/acs.accounts.8b00066. Epub 2018 Jun 5. Acc Chem Res. 2018. PMID: 29870227 Free PMC article.
Complexes bearing ancillary ligands with denticities higher than three represent a new class of Ru(II)-based photocaging groups that are grossly underdeveloped. ...Furthermore, the introduction of steric bulk enhances the photoliability of the caged molecules, valid …
Complexes bearing ancillary ligands with denticities higher than three represent a new class of Ru(II)-based photocaging group …
Selective, Disruptive Luminescent Ru(II) Polypyridyl Probes of G-Quadruplex.
Holden L, Gkika KS, Burke CS, Long C, Keyes TE. Holden L, et al. Inorg Chem. 2023 Feb 6;62(5):2213-2227. doi: 10.1021/acs.inorgchem.2c03903. Epub 2023 Jan 26. Inorg Chem. 2023. PMID: 36703307 Free PMC article.
While the majority of Ru(II)-based light switches reported to date, stabilize the quadruplex, imaging/theranostic probes that can disrupt G4s are of potentially enormous value in study and therapy for a range of disease states. We report here, on a Ru(II …
While the majority of Ru(II)-based light switches reported to date, stabilize the quadruplex, imaging/theranostic probes that …
All-trans-[ClRu(II)(py)4(NC)Ru(II)(py)4(CN)Ru(II)(py)4(NO)](PF6)4: a redox-active 2-donor/1-acceptor system based on the electrophilic {RuNO}6 motif.
De Candia AG, Singh P, Kaim W, Slep LD. De Candia AG, et al. Inorg Chem. 2009 Jan 19;48(2):565-73. doi: 10.1021/ic801347d. Inorg Chem. 2009. PMID: 19093847
The new linear homotrinuclear compound trans-[ClRu(II)(py)(4)(NC)Ru(II)(py)(4)(CN)Ru(II)(py)(4)(NO)](PF(6))(4) was prepared by reaction between the nitro complex trans-[(NC)Ru(II)(py)(4)(CN)Ru(II)(py)(4)(NO(2))](+) an …
The new linear homotrinuclear compound trans-[ClRu(II)(py)(4)(NC)Ru(II)(py)(4)(CN)Ru(II)(py)(4)(NO)](PF(6 …
Multiple MMCT properties of the diruthenium-based cyanido-bridged complex RuVI2-NC-Ru(II)-CN-RuVI2.
Su SD, Wen YH, Wu XT, Sheng TL. Su SD, et al. Dalton Trans. 2022 Jul 5;51(26):10047-10054. doi: 10.1039/d2dt00408a. Dalton Trans. 2022. PMID: 35726780
The diruthenium-based linear mixed valence complex trans-[Ru(2)(ap)(4)-NC-Ru(DMAP)(4)-CN-Ru(2)(ap)(4)][PF(6)](2) (12+[PF6]2) (ap = 2-anilinopyridinate, DMAP = 4-dimethylaminopyridine) and its two-electron oxidation product 14+[PF6]4 have been synthesized and …
The diruthenium-based linear mixed valence complex trans-[Ru(2)(ap)(4)-NC-Ru(DMAP)(4)-CN-Ru(2)(ap)(4)][PF(6)](2) (12+[P …
Two photoactive Ru (II) compounds based on tetrazole ligands for photodynamic therapy.
Yang J, He X, Ke Z, Chen J, Zou Z, Wei B, Zou D, Zou J. Yang J, et al. J Inorg Biochem. 2020 Sep;210:111127. doi: 10.1016/j.jinorgbio.2020.111127. Epub 2020 Jun 1. J Inorg Biochem. 2020. PMID: 32521288
Ru (II) compounds have potential application in photodynamic therapy (PDT). In the current study, two Ru (II) compounds based on the auxiliary ligand 2,2'-bipyridine (bipy) by changing main ligands 5-(2-pyridyl) tetrazole (Hpytz) and di(2H-tetrazol-5-y …
Ru (II) compounds have potential application in photodynamic therapy (PDT). In the current study, two Ru (II) co …
11,208 results
You have reached the last available page of results. Please see the User Guide for more information.